Skip to main content
Livermore
Livermore
ZHEN

Prosight Management, LP

SEC CIK
0001617201
Latest filing
Aug 14, 2026

Holdings in Q2 2022

Holdings as of Jun 30, 2022, filed Aug 12, 2022. Long positions only; changes compare share counts with Q1 2022.

Institution overview
Positions
23
−7 vs. Q1 2022
Portfolio value
$123.5M
−$18.6M (−13.1%) vs. Q1 2022
Filed
Aug 12, 2022
SEC
Holdings of Prosight Management, LP in Q2 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
LKFTLakefront Biotherapeutics NVSPON ADR369,000$20.6M16.7%−5,000−1.3%ReducedHistory
PRTAProthena Corp Public Ltd CoSHS550,000$14.9M12.1%−16,538−2.9%ReducedHistory
KZRKezar Life Sciences, Inc.COM1,262,691$10.4M8.5%+962,691+320.9%AddedHistory
ALBOAlbireo Pharma, Inc.COM467,795$9.29M7.5%−12,205−2.5%ReducedHistory
KALVKalVista Pharmaceuticals, Inc.COM820,752$8.08M6.5%+231,482+39.3%AddedHistory
ALDXAldeyra Therapeutics, Inc.COM1,985,883$7.92M6.4%+585,644+41.8%AddedHistory
MGTXMeiraGTx Holdings plcCOM986,218$7.47M6.0%+605,518+159.1%AddedHistory
CRLCharles River Laboratories International, Inc.COM27,500$5.88M4.8%−4,000−12.7%ReducedHistory
ONEM1Life Healthcare IncCOM725,000$5.68M4.6%+725,000NewHistory
QDELQuidelOrtho CorpCOM46,576$4.53M3.7%+20,901+81.4%AddedHistory
STTKShattuck Labs, Inc.COM1,020,000$4.14M3.4%+221,282+27.7%AddedHistory
CUECue Biopharma, Inc.COM1,655,477$4.12M3.3%+145,195+9.6%AddedHistory
RCKTRocket Pharmaceuticals, Inc.COM276,802$3.81M3.1%+73,534+36.2%AddedHistory
GBTGlobal Blood Therapeutics, Inc.COM101,847$3.25M2.6%+101,847NewHistory
MIRMMirum Pharmaceuticals, Inc.COM161,527$3.14M2.5%+87,597+118.5%AddedHistory
THCTenet Healthcare CorpCOM NEW50,700$2.67M2.2%+50,700NewHistory
BCRXBiocryst Pharmaceuticals IncCOM176,680$1.87M1.5%+176,680NewHistory
SPRYARS Pharmaceuticals, Inc.COM341,108$1.45M1.2%+15,743+4.8%AddedHistory
PRQRProQR Therapeutics N.V.SHS EURO1,707,509$1.33M1.1%+1,108,221+184.9%AddedHistory
ARDXArdelyx, Inc.COM2,163,520$1.28M1.0%+2,163,520NewHistory
INMDInMode Ltd.SHS45,000$1.01M0.8%−5,000−10.0%ReducedHistory
APENApollo Endosurgery, Inc.COM90,176$329.0K0.3%+90,176NewHistory
CGTXCognition Therapeutics IncCOM120,198$254.0K0.2%−119,882−49.9%ReducedHistory

Options (1)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Prosight Management, LP in Q2 2022
SecurityClassPutsCalls
1LIFE Healthcare Inc68269G907CALL–$3.45M

Sold out since Q1 2022 (13)

Positions held at the end of Q1 2022 that are gone from this filing.

Positions of Prosight Management, LP sold out since Q1 2022
SecurityClassShares in Q1 2022Value in Q1 2022% of portfolio in Q1 2022History
CNVYConvey Health Solutions Holdings, Inc.COM748,134$4.89M3.4%History
ALNYAlnylam Pharmaceuticals, Inc.COM22,704$3.71M2.6%History
AGLagilon health, inc.COM140,000$3.55M2.5%History
EHCEncompass Health CorpCOM39,900$2.84M2.0%History
OSCROscar Health, Inc.CL A237,500$2.37M1.7%History
ACCDAccolade, Inc.COM124,393$2.18M1.5%History
SEMSelect Medical Holdings CorpCOM90,788$2.18M1.5%History
CRSPCRISPR Therapeutics AGNAMEN AKT34,000$2.13M1.5%History
GMEDGlobus Medical IncStock18,000$1.33M0.9%History
NEONeogenomics IncCOM NEW63,524$772.0K0.5%History
SIOXSio Gene Therapies Inc.COMMON670,300$449.0K0.3%History
IOVAIovance Biotherapeutics, Inc.COM20,000$333.0K0.2%History
CBAYCymaBay Therapeutics, Inc.COM93,923$292.0K0.2%History